SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-24-005896
Filing Date
2024-01-19
Accepted
2024-01-19 19:23:27
Documents
1
Period of Report
2024-01-11

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 4211
  Complete submission text file 0000950170-24-005896.txt   6504
Mailing Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129
Business Address 500 RUTHERFORD AVENUE 3RD FLOOR CHARLESTOWN MA 02129 617-337-4680
Solid Biosciences Inc. (Issuer) CIK: 0001707502 (see all company filings)

IRS No.: 900943402 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 200 CLARENDON BOSTON MA 02116
Business Address 200 CLARENDON BOSTON MA 02116 6175162000
BCLS II Equity Opportunities, LP (Reporting) CIK: 0001814474 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 24546796

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 6175162000
BCLS II Equity Opportunities GP, LLC (Reporting) CIK: 0002008174 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-38360 | Film No.: 24546797